Jensen JB - Search Results

1

High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer.

Laurberg JR, Jensen JB, Schepeler T, Borre M, Ørntoft TF, Dyrskjøt L. Laurberg JR, et al. Among authors: jensen jb. BMC Cancer. 2014 Aug 30;14:638. doi: 10.1186/1471-2407-14-638. BMC Cancer. 2014. PMID: 25175477 Free PMC article.

2

High expression of karyopherin-α2 defines poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomy.

Jensen JB, Munksgaard PP, Sørensen CM, Fristrup N, Birkenkamp-Demtroder K, Ulhøi BP, Jensen KM, Ørntoft TF, Dyrskjøt L. Jensen JB, et al. Among authors: jensen km. Eur Urol. 2011 May;59(5):841-8. doi: 10.1016/j.eururo.2011.01.048. Epub 2011 Feb 16. Eur Urol. 2011. PMID: 21330047

3

Incidence of occult lymph-node metastasis missed by standard pathological examination in patients with bladder cancer undergoing radical cystectomy.

Jensen JB, Høyer S, Jensen KM. Jensen JB, et al. Among authors: jensen km. Scand J Urol Nephrol. 2011 Dec;45(6):419-24. doi: 10.3109/00365599.2011.599336. Epub 2011 Jul 19. Scand J Urol Nephrol. 2011. PMID: 21767245

4

Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer.

Laurberg JR, Brems-Eskildsen AS, Nordentoft I, Fristrup N, Schepeler T, Ulhøi BP, Agerbaek M, Hartmann A, Bertz S, Wittlinger M, Fietkau R, Rödel C, Borre M, Jensen JB, Orntoft T, Dyrskjøt L. Laurberg JR, et al. Among authors: jensen jb. BJU Int. 2012 Dec;110(11 Pt C):E1228-36. doi: 10.1111/j.1464-410X.2012.11564.x. Epub 2012 Oct 9. BJU Int. 2012. PMID: 23046361

5

Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer.

Teo MTW, Dyrskjøt L, Nsengimana J, Buchwald C, Snowden H, Morgan J, Jensen JB, Knowles MA, Taylor G, Barrett JH, Borre M, Ørntoft TF, Bishop DT, Kiltie AE. Teo MTW, et al. Among authors: jensen jb. Ann Oncol. 2014 Apr;25(4):877-883. doi: 10.1093/annonc/mdu014. Epub 2014 Mar 12. Ann Oncol. 2014. PMID: 24623370 Free PMC article.

6

Multidisciplinary rehabilitation can impact on health-related quality of life outcome in radical cystectomy: secondary reported outcome of a randomized controlled trial.

Jensen BT, Jensen JB, Laustsen S, Petersen AK, Søndergaard I, Borre M. Jensen BT, et al. Among authors: jensen jb. J Multidiscip Healthc. 2014 Jul 16;7:301-11. doi: 10.2147/JMDH.S62172. eCollection 2014. J Multidiscip Healthc. 2014. PMID: 25075194 Free PMC article.

7

Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties.

Ostenfeld MS, Jeppesen DK, Laurberg JR, Boysen AT, Bramsen JB, Primdal-Bengtson B, Hendrix A, Lamy P, Dagnaes-Hansen F, Rasmussen MH, Bui KH, Fristrup N, Christensen EI, Nordentoft I, Morth JP, Jensen JB, Pedersen JS, Beck M, Theodorescu D, Borre M, Howard KA, Dyrskjøt L, Ørntoft TF. Ostenfeld MS, et al. Among authors: jensen jb. Cancer Res. 2014 Oct 15;74(20):5758-71. doi: 10.1158/0008-5472.CAN-13-3512. Epub 2014 Sep 26. Cancer Res. 2014. PMID: 25261234 Free article.

8

Efficacy of a multiprofessional rehabilitation programme in radical cystectomy pathways: a prospective randomized controlled trial.

Jensen BT, Petersen AK, Jensen JB, Laustsen S, Borre M. Jensen BT, et al. Among authors: jensen jb. Scand J Urol. 2015 Apr;49(2):133-41. doi: 10.3109/21681805.2014.967810. Epub 2014 Oct 21. Scand J Urol. 2015. PMID: 25331367 Clinical Trial.

9

Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer.

Birkenkamp-Demtröder K, Nordentoft I, Christensen E, Høyer S, Reinert T, Vang S, Borre M, Agerbæk M, Jensen JB, Ørntoft TF, Dyrskjøt L. Birkenkamp-Demtröder K, et al. Among authors: jensen jb. Eur Urol. 2016 Jul;70(1):75-82. doi: 10.1016/j.eururo.2016.01.007. Epub 2016 Jan 20. Eur Urol. 2016. PMID: 26803478

10

Exercise-based pre-habilitation is feasible and effective in radical cystectomy pathways-secondary results from a randomized controlled trial.

Jensen BT, Laustsen S, Jensen JB, Borre M, Petersen AK. Jensen BT, et al. Among authors: jensen jb. Support Care Cancer. 2016 Aug;24(8):3325-31. doi: 10.1007/s00520-016-3140-3. Epub 2016 Mar 10. Support Care Cancer. 2016. PMID: 26961741 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

477 results

Search Page